MUDr. Dana Maňasková

  • medicinman.cz
  • Zájmy a činnosti
  • Nemoci a symptomy
  • Léky, látky a laboratorní testy
  • Postupy, metody a terapie
  • Dietologie a potravinářství
  • P-o-traviny, rostliny aj.
  • Papírování
  • Zajímaví lidé a činnosti
  • Odborná pracoviště
  • Odborné odkazy
  • Obecné odkazy a tipy
  • Kalendář akcí
  • CV a kredity
  • Fantazie, nápady a snění
  • GDPR

Vyhledávání na medicinman.cz
 

Silymarin

Z rostliny

  • Ostropestřec mariánský
  • milk thistle
  • Silybum marianum

Farmakodynamika silymarinu

  • Orally absorbed
  • Excreted mainly through bile
    • Sulphates
    • Conjugates [1]

Složení silymarinu

  • 4 flavonolignan isomers:
    • Silybin
      • The most active and commonly used
    • Isosilybin
    • Silydianin
    • Silychristin [1]

Vlastnosti silymarinu

  • Good protection in various toxic models of experimental liver diseases in laboratory animals
  • Antioxidative
  • Anti-lipid peroxidative
  • Antifibrotic
  • Anti-inflammatory
  • Membrane stabilizing
  • Immunomodulatory [1]
    • Selectively inhibits leukotriene formation by Kupffer cells [1]
  • Liver regenerating [1]

Indikace

  • Alcoholic liver diseases
  • Liver cirrhosis
  • Amanita mushroom poisoning
  • Viral hepatitis
  • Toxic and drug induced liver diseases
  • Diabetic patients
  • Does not have antiviral properties against hepatitis virus
    • Promotes protein synthesis
    • Helps in regenerating liver tissue
    • Controls inflammation
    • Enhances glucuronidation
    • Protects against glutathione depletion [1]
  • Hepatobiliary diseases
  • Hepatotoxicity due to drugs
  • New approach to protect other organs in addition to liver [1]

Výhody

  • Good safety profile
  • Better patient tolerability
  • Effective drug
  • Affordable price [1]

Ekonomie

  • 180 million US dollars business in Germany alone [1]
Literatura:

[1] Hepatoprotective herbal drug, silymarin fro... [Indian J Med Res. 2006] - PubMed - NCBI [Internet]. [citován 2012 říj 1]. Available z: www.ncbi.nlm.nih.gov/pubmed/17213517



O úroveň výše

Poslední aktualizace: 2. 10. 2012 0:49:09
© Dana Maňasková, metabalance.cz
e-mail